Characterization of lymphocytes that suppress EAE
抑制 EAE 的淋巴细胞的表征
基本信息
- 批准号:8088992
- 负责人:
- 金额:$ 39.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-02 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAntigen-Presenting CellsAntigensApoptosisAutoimmune ProcessBiologicalCD28 geneCD4 Positive T LymphocytesCellsCellular biologyCharacteristicsChronicColitisCytokine ReceptorsDendritic CellsDependenceEventExperimental Autoimmune EncephalomyelitisFrequenciesFundingGenerationsGrantIL2RA geneIgEImageImmune responseImmune systemInflammatoryInterleukin-10Interleukin-2KnowledgeLymphocyteMediatingModelingMultiple SclerosisMusMyelin Basic ProteinsPatternPropertyRegulatory T-LymphocyteRelative (related person)RoleSignal TransductionSpecificitySpleenStructure of parenchyma of lungT-Cell ReceptorT-LymphocyteTestingTimeTransgenic MiceWorkallergic responsecentral nervous system demyelinating disorderclinical applicationcytokinedesignimmunogenicimmunoregulationin vivointravital microscopymigrationpreventresearch studyresponsetwo-photon
项目摘要
Experimental autoimmune encephalomyelitis is an inflammatory demyelinating
disease of the central nervous system (CNS) studied as a model of multiple
sclerosis. Mice which harbor a monoclonal myelin basic protein (MBP)-specific
ab T cell compartment develop EAE spontaneously. EAE can be prevented in
these mice by the administration of a small number of polyclonal CD4+ T cells
(regulatory T cells or T-reg) belonging to either the CD4+CD25+ or the
CD4+CD25- T cell subpopulations. The biological impact of T-reg administration
is large, and, therefore, so is its potential for clinical application, yet many
important properties of T-reg cells that control spontaneous EAE remain poorly
understood. This application focuses on key events involved in
immunoregulation of spontaneous EAE in MBP-specific T cell receptor
transgenic mice. In Aim 1, we will assess the role of the cytokines, cytokine
receptors and co-stimulatory molecules IL-2, CD25, IL-10, TGF-b and CD28 in
the generation, survival and function of T-reg. A better knowledge of T-reg
dependence on these cytokines and co-stimulatory signals may enhance the
potential of in vivo manipulation of immunoregulatory T cells. In Aim 2, we will
investigate the MHC restriction of regulatory T cells. The characteristics of MHC
restriction of T-reg cells may help in the design of strategies to purify these cells
out of the total CD4+ T cell compartment.
实验性自身免疫性脑脊髓炎是一种炎症性脱髓鞘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Juan Lafaille其他文献
Juan Lafaille的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Juan Lafaille', 18)}}的其他基金
The role of brain border-associated macrophages in aging and cerebral amyloid angiopathy
脑边界相关巨噬细胞在衰老和脑淀粉样血管病中的作用
- 批准号:
10367690 - 财政年份:2022
- 资助金额:
$ 39.8万 - 项目类别:
The role of brain border-associated macrophages in aging and cerebral amyloid angiopathy
脑边界相关巨噬细胞在衰老和脑淀粉样血管病中的作用
- 批准号:
10551329 - 财政年份:2022
- 资助金额:
$ 39.8万 - 项目类别:
Thymic selection of Foxp3+ regulatory T cells
Foxp3 调节性 T 细胞的胸腺选择
- 批准号:
8122891 - 财政年份:2010
- 资助金额:
$ 39.8万 - 项目类别:
Charaterizing lymphocytes that suppress Experimental Autoimmune Encephalomyelitis
表征抑制实验性自身免疫性脑脊髓炎的淋巴细胞
- 批准号:
7208963 - 财政年份:1998
- 资助金额:
$ 39.8万 - 项目类别:
相似海外基金
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的三信号人工抗原呈递细胞
- 批准号:
10751133 - 财政年份:2023
- 资助金额:
$ 39.8万 - 项目类别:
Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy
用于癌症免疫治疗的微流控精密工程人工抗原呈递细胞
- 批准号:
10696138 - 财政年份:2022
- 资助金额:
$ 39.8万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10663066 - 财政年份:2022
- 资助金额:
$ 39.8万 - 项目类别:
The role of microglia as antigen presenting cells in Globoid Cell Leukodystrophy
小胶质细胞作为抗原呈递细胞在球状细胞脑白质营养不良中的作用
- 批准号:
10537159 - 财政年份:2022
- 资助金额:
$ 39.8万 - 项目类别:
Analysis of the function of antigen-presenting cells present in the stroma of colorectal cancer and the intracellular microbiome
结直肠癌基质中抗原呈递细胞和细胞内微生物组的功能分析
- 批准号:
21K08723 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10156950 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
The role of CX3CR1+ antigen presenting cells in T cell selection and central tolerance"
CX3CR1抗原呈递细胞在T细胞选择和中枢耐受中的作用"
- 批准号:
10631854 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
Reprogramming Cancer Cells into Antigen Presenting Cells: Cancer Vaccination with mRNA Enabled by Charge-Altering Releasable Transporters
将癌细胞重编程为抗原呈递细胞:通过改变电荷的可释放转运蛋白实现 mRNA 的癌症疫苗接种
- 批准号:
10153927 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
Class II artificial antigen presenting cells for cancer immunotherapy
用于癌症免疫治疗的 II 类人工抗原呈递细胞
- 批准号:
10331830 - 财政年份:2021
- 资助金额:
$ 39.8万 - 项目类别:
Analysis on detrimental interplay between pathogenic helper T cells, inflammatory antigen-presenting cells and disease-associated microglia in chronic pathogenesis of multiple sclerosis
多发性硬化症慢性发病机制中致病性辅助 T 细胞、炎症抗原呈递细胞和疾病相关小胶质细胞之间的有害相互作用分析
- 批准号:
20K16294 - 财政年份:2020
- 资助金额:
$ 39.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists